Celldex Therapeutics, Inc.
US ˙ NasdaqCM ˙ US15117B2025

SecurityCLDX / Celldex Therapeutics, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in CLDX / Celldex Therapeutics, Inc.

On May 15, 2024 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Celldex Therapeutics, Inc. (US:CLDX) valued at $0 USD as of March 31, 2024. The entity filed a previous 13F-HR on February 14, 2024 disclosing 5,058 shares of Celldex Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (CLDX) in the form of stock options. The firm currently holds call options representing 17,900 of underlying shares valued at $468,801 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CLDX / Celldex Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-05-15 2024-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -5,058 -100.00 0 -100.00
2024-02-14 2023-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 5,058 5,058 201 0.0002
2019-11-14 2019-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 0 -10,852 -100.00 0 -100.00
2019-08-20 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 10,852 -10,065 -48.12 29 -71.84 0.0001
2019-05-15 2019-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 20,917 20,917 103 0.0003
2018-05-15 2018-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -22,328 -100.00 0 -100.00
2018-02-14 2017-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 22,328 -7,796 -25.88 63 -26.74 0.0002
2017-11-15 2017-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 30,124 -9,002 -23.01 86 -12.24 0.0003
2017-08-14 2017-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 39,126 3,102 8.61 98 -24.62 0.0005
2017-05-15 2017-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 36,024 36,024 130 0.0007
2016-11-14 2016-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 0 -862 -100.00 0 -100.00
2016-08-15 2016-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 862 862 4 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 17,900 67.29 469 115.67 n/a n/a n/a
2025-08-18 2025-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 10,700 217 n/a n/a n/a
2025-05-15 2025-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 10,200 -22.14 256 -41.01 n/a n/a n/a
2024-11-14 2024-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 13,100 435 n/a n/a n/a
2023-08-23 2023-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 n/a n/a n/a
2023-05-15 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 8,800 51.72 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 5,800 259 n/a n/a n/a
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 32,300 108.39 899 67.72 n/a n/a n/a
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 15,500 29.17 536 14.78 n/a n/a n/a
2022-02-14 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 12,000 106.90 467 55.15 n/a n/a n/a
2021-11-12 2021-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 5,800 301 n/a n/a n/a
2021-02-12 2020-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 23,000 105.36 349 149.29 n/a n/a n/a
2020-08-13 2020-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 11,200 -5.88 140 566.67 n/a n/a n/a
2020-05-11 2020-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 11,900 21 n/a n/a n/a
2020-02-12 2019-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 21,500 14.97 47 -6.00 n/a n/a n/a
2019-08-20 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Call 18,700 -21.43 50 -57.26 n/a n/a n/a
2019-05-15 2019-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Call 23,800 117 n/a n/a n/a
2019-02-13 2018-12-31 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F CELLDEX THERAPEUTICS INC COM Call 17,200 8 n/a n/a n/a
2018-05-15 2018-03-31 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F CELLDEX THERAPEUTICS INC COM Call 42,000 -30.92 119 -31.61 n/a n/a n/a
2017-11-15 2017-09-30 13F CELLDEX THERAPEUTICS INC COM Call 60,800 69.83 174 93.33 n/a n/a n/a
2017-08-14 2017-06-30 13F CELLDEX THERAPEUTICS INC COM Call 35,800 -50.14 90 -65.12 n/a n/a n/a
2017-05-15 2017-03-31 13F CELLDEX THERAPEUTICS INC COM Call 71,800 258 n/a n/a n/a
2016-11-14 2016-09-30 13F CELLDEX THERAPEUTICS INC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-17 2016-06-30 13F/A CELLDEX THERAPEUTICS INC COM Call 63,900 282 n/a n/a n/a
2016-08-15 2016-06-30 13F CELLDEX THERAPEUTICS INC COM Call 639 282 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-05-15 2024-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 14,400 16.13 571 67.45 n/a n/a n/a
2023-11-15 2023-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 12,400 -12.68 341 -30.55 n/a n/a n/a
2023-08-23 2023-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 14,200 491 n/a n/a n/a
2023-05-15 2023-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 5,300 236 n/a n/a n/a
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 16,900 59.43 470 28.07 n/a n/a n/a
2022-05-16 2022-03-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 10,600 -13.11 367 -22.74 n/a n/a n/a
2022-02-14 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW Put 12,200 79.41 475 34.56 n/a n/a n/a
2021-11-12 2021-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 6,800 353 n/a n/a n/a
2020-11-13 2020-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 11,000 137 n/a n/a n/a
2019-11-14 2019-09-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-20 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW Put 10,700 29 n/a n/a n/a
2018-05-15 2018-03-31 13F CELLDEX THERAPEUTICS INC COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F CELLDEX THERAPEUTICS INC COM Put 26,400 -26.05 75 -26.47 n/a n/a n/a
2017-11-15 2017-09-30 13F CELLDEX THERAPEUTICS INC COM Put 35,700 -21.19 102 -9.73 n/a n/a n/a
2017-08-14 2017-06-30 13F CELLDEX THERAPEUTICS INC COM Put 45,300 -31.78 113 -52.72 n/a n/a n/a
2017-05-15 2017-03-31 13F CELLDEX THERAPEUTICS INC COM Put 66,400 16.90 239 -4.78 n/a n/a n/a
2016-08-17 2016-06-30 13F/A CELLDEX THERAPEUTICS INC COM Put 56,800 251 n/a n/a n/a
2016-08-15 2016-06-30 13F CELLDEX THERAPEUTICS INC COM Put 568 251 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.